Follow the 비보존 제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 비보존 제약 has published 101 reports. Market capitalisation: €198.6bn. The latest transaction was disclosed on 10 July 2026 (Other). Among the most active insiders: 비보존홀딩스. All data is accessible without an account.
97
Insider Decl.
n/a
Thresholds
€2m
51 ops.
Buy Volume
€314,335
8 ops.
Sell Volume
19Σ signal
Buys €2m€314,335 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,565 of 29,062 companies
24.1
score / 100
Value
18
Quality
30
FCF yld-4.6%
Earn yld-16%
EV/EBITDA·
ROE·
Gross mgn41%
Net mgn-55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.